CompanyGraph
What stands out
- Returns appear driven by leverage
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.4B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.71: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.39%Below 5Y avg (2.53%)
Annual Rate
USD 0.48Paid quarterly
Payout Ratio
19.8%Sustainable
Paying Dividends
13 yr
Payback Period
77.6 yr
Last Ex-Dividend
Sep 2, 2026
Last Payment
Sep 23, 2026
The reported statements, read against the company's own industry.
What stands out
- Returns appear driven by leverage
Financials view
Market Capitalization
1.40BUSDvs all stocks (USD)
Trailing P/E
14.18xRevenue (TTM)
1.52BUSDvs all stocks (USD)
Profit Margin
6.57%Beta
0.4650xvs all stocks
52-Week Change
-12.01%vs all stocks
Forward Annual Dividend Yield
1.39%vs all stocks
Market Capitalization
1.40BUSDvs all stocks (USD)
Enterprise Value
2.11BUSDvs all stocks (USD)
Trailing P/E
14.18xForward P/E
8.95xPEG Ratio
0.4962xPrice to Sales (TTM)
0.9214xPrice to Book (MRQ)
3.63xEnterprise to Revenue
1.39xEnterprise to EBITDA
8.64xGross Margin
33.88%Profit Margin
6.57%Operating Margin
10.64%Return on Assets (TTM)
8.48%Return on Equity (TTM)
29.72%Revenue (TTM)
1.52BUSDvs all stocks (USD)
Revenue per Share (TTM)
37.44USDUpdated Sep 28, 2026Quarterly Revenue Growth
4.80%Gross Profit (TTM)
505.97MUSDvs all stocks (USD)
EBITDA (TTM)
245.51MUSDvs all stocks (USD)
Net Income (TTM)
99.72MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
26.00%Operating Cash Flow (TTM)
68.95MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-19.30MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.4800USDUpdated Sep 28, 2026Forward Annual Dividend Yield
1.39%vs all stocks
Trailing Annual Dividend Rate
0.4800USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
1.39%vs all stocks
5-Year Average Dividend Yield
2.53%vs all stocks
Payout Ratio
19.75%Revenue
1.30BUSDFY2025 · Jun 30, 2025Cost of Goods Sold
896.27MUSDFY2025 · Jun 30, 2025Gross Profit
399.94MUSDFY2025 · Jun 30, 2025Operating Income
110.47MUSDvs all stocks (USD)
Pre-tax Income
67.99MUSDFY2025 · Jun 30, 2025Income Tax Expense
19.73MUSDFY2025 · Jun 30, 2025Net Income
48.26MUSDFY2025 · Jun 30, 2025EBIT
101.24MUSDFY2025 · Jun 30, 2025EBITDA (Income Statement)
154.72MUSDFY2025 · Jun 30, 2025Selling, General & Administrative
289.48MUSDFY2025 · Jun 30, 2025Non-operating Interest Income
2.62MUSDFY2025 · Jun 30, 2025Non-operating Interest Expense
33.25MUSDFY2025 · Jun 30, 2025EPS (Basic)
1.19USDFY2025 · Jun 30, 2025EPS (Diluted)
1.19USDFY2025 · Jun 30, 2025Basic Shares Outstanding
40.50MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
40.50MSharesFY2025 · Jun 30, 2025Net Income from Continuing Operations
48.26MUSDFY2025 · Jun 30, 2025Operating Cash Flow
27.04MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
68.04MUSDFY2025 · Jun 30, 2025Income Tax Paid
13.40MUSDFY2025 · Jun 30, 2025Interest Paid
32.07MUSDFY2025 · Jun 30, 2025Starting Profit (CF Statement)
48.26MUSDFY2025 · Jun 30, 2025Depreciation & Amortization
45.60MUSDFY2025 · Jun 30, 2025Deferred Taxes (CF)
-4.88MUSDFY2025 · Jun 30, 2025Stock-based Compensation
717.00KUSDFY2025 · Jun 30, 2025Other Non-cash Items
6.05MUSDFY2025 · Jun 30, 2025Change in Accounts Receivable (CF)
-55.21MUSDFY2025 · Jun 30, 2025Change in Accounts Payable (CF)
45.55MUSDFY2025 · Jun 30, 2025Change in Other Assets/Liabilities
-59.07MUSDFY2025 · Jun 30, 2025Net Acquisitions
-286.53MUSDFY2025 · Jun 30, 2025Purchase of Investments
-14.00MUSDFY2025 · Jun 30, 2025Sale of Investments
49.00MUSDFY2025 · Jun 30, 2025Other Investing Activity
1.13MUSDFY2025 · Jun 30, 2025Net Investing Cash Flow
-250.40MUSDFY2025 · Jun 30, 2025Long-term Debt Issuance
1.18BUSDFY2025 · Jun 30, 2025Long-term Debt Payments
-946.01MUSDFY2025 · Jun 30, 2025Common Dividends Paid
-19.45MUSDFY2025 · Jun 30, 2025Other Financing Charges
-9.40MUSDFY2025 · Jun 30, 2025Net Financing Cash Flow
207.13MUSDFY2025 · Jun 30, 2025Shares Outstanding
40.56MSharesUpdated Sep 28, 2026Float Shares
20.91MSharesUpdated Sep 28, 2026Shares Short
1.14MSharesUpdated Sep 28, 2026Short Ratio
4.68daysvs all stocks
Short % of Shares Outstanding
6.43%vs all stocks
% Held by Insiders
0.87%vs all stocks
% Held by Institutions
103.98%vs all stocks
Total Cash (MRQ)
83.98MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.07USDUpdated Sep 28, 2026Total Debt (MRQ)
795.65MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
2.06xCurrent Ratio (MRQ)
2.96xBook Value per Share (MRQ)
9.50USDUpdated Sep 28, 2026Total Assets
1.36BUSDvs all stocks (USD)
Total Current Assets
810.61MUSDFY2025 · Jun 30, 2025Total Liabilities
1.08BUSDFY2025 · Jun 30, 2025Total Non-current Assets
550.29MUSDFY2025 · Jun 30, 2025Total Non-current Liabilities
781.75MUSDFY2025 · Jun 30, 2025Total Current Liabilities
293.47MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents
68.04MUSDFY2025 · Jun 30, 2025Other Short-term Investments
9.00MUSDFY2025 · Jun 30, 2025Accounts Receivable
227.98MUSDFY2025 · Jun 30, 2025Inventory
444.43MUSDFY2025 · Jun 30, 2025Accounts Payable
138.20MUSDFY2025 · Jun 30, 2025Short-term Debt
25.38MUSDFY2025 · Jun 30, 2025Other Current Liabilities
31.24MUSDFY2025 · Jun 30, 2025Long-term Debt
736.17MUSDFY2025 · Jun 30, 2025Other Non-current Liabilities
11.36MUSDFY2025 · Jun 30, 2025Common Stock (Book)
4.00KUSDFY2025 · Jun 30, 2025Retained Earnings
272.70MUSDFY2025 · Jun 30, 2025Total Shareholders' Equity
285.68MUSDvs all stocks (USD)
52-Week Low
28.25USDUpdated Sep 28, 202652-Week High
60.08USDUpdated Sep 28, 202652-Week Change
-12.01%vs all stocks
Beta
0.4650xvs all stocks
50-Day MA
35.56USDUpdated Sep 28, 2026200-Day MA
41.42USDUpdated Sep 28, 2026Avg 10-Day Volume
252.22KSharesUpdated Sep 28, 2026Avg 30-Day Volume
239.13KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
2.43USDUpdated Sep 28, 2026Other Income / Expense
-7.87MUSDFY2025 · Jun 30, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Returns appear driven by leverageSignificant
Return on Equity: 0.30Debt-to-Equity: 2.06
Financial Health
Altman Z-Score 2.71: safe zoneNotable
Altman Z-Score: 2.71
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.4B, above the global median of $1.18BNotable
Market cap (USD): 1,398,725,223Global Median: 1,180,223,658.953
Revenue is $1.52B, above the global median of $548.88MNotable
Revenue (USD): 1,518,093,056Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Pacific Shuanglin Bio-Pharmacy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arrivent Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Jolly Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
SUDEEPPHRM
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Genrix Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ultragenyx Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Oric Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Chase Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
KalVista Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Steel Strips Wheels Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Syngene International Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Tata Consumer Products Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth